Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001209191-23-052782

Options or other derivatives

  • Corporate Controller acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Trojanowski Justin Corporate Controller 2023-10-11 Grant or award · Employee Stock Option (right to buy) +55,000 55,000 D
Loading xslF345X05/doc4.xml…